Integrated Filing- Financial

Valiant Laboratories has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The standalone revenue from operations for the quarter reached ₹3,522.84 crore, with a net profit of ₹160.01 crore.

Total income stood at ₹3,589.46 crore.

The consolidated results reflected similar growth, with consolidated revenues at ₹3,523.30 crore and a profit of ₹234.51 crore.

This positive performance suggests improved operational efficiency, which may enhance investor sentiment and reflects the company’s potential for continued growth, positioning it favorably in the market.